HEADER HYDROLASE 28-JUL-05 2AHG TITLE UNSATURATED GLUCURONYL HYDROLASE MUTANT D88N WITH DGLCA-GALNAC COMPND MOL_ID: 1; COMPND 2 MOLECULE: UNSATURATED GLUCURONYL HYDROLASE; COMPND 3 CHAIN: A, B; COMPND 4 EC: 3.2.1.-; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BACILLUS SP.; SOURCE 3 ORGANISM_TAXID: 84635; SOURCE 4 STRAIN: GL1; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET3A KEYWDS ALPHA6/ALPHA6 BARREL, GLYCOSIDE HYDROLASE FAMILY 88, COMPLEX WITH KEYWDS 2 UNSATURATED CHONDROITIN DISACCHARIDE, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR T.ITOH,W.HASHIMOTO,B.MIKAMI,K.MURATA REVDAT 7 29-MAY-24 2AHG 1 REMARK REVDAT 6 10-NOV-21 2AHG 1 SEQADV HETSYN REVDAT 5 29-JUL-20 2AHG 1 COMPND REMARK HET HETNAM REVDAT 5 2 1 HETSYN FORMUL LINK SITE REVDAT 5 3 1 ATOM REVDAT 4 13-JUL-11 2AHG 1 VERSN REVDAT 3 24-FEB-09 2AHG 1 VERSN REVDAT 2 17-OCT-06 2AHG 1 JRNL REVDAT 1 15-AUG-06 2AHG 0 JRNL AUTH T.ITOH,W.HASHIMOTO,B.MIKAMI,K.MURATA JRNL TITL CRYSTAL STRUCTURE OF UNSATURATED GLUCURONYL HYDROLASE JRNL TITL 2 COMPLEXED WITH SUBSTRATE: MOLECULAR INSIGHTS INTO ITS JRNL TITL 3 CATALYTIC REACTION MECHANISM JRNL REF J.BIOL.CHEM. V. 281 29807 2006 JRNL REFN ISSN 0021-9258 JRNL PMID 16893885 JRNL DOI 10.1074/JBC.M604975200 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 14.96 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 2825270.900 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 91.3 REMARK 3 NUMBER OF REFLECTIONS : 58009 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.184 REMARK 3 FREE R VALUE : 0.235 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.200 REMARK 3 FREE R VALUE TEST SET COUNT : 5900 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.003 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.02 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 71.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 6706 REMARK 3 BIN R VALUE (WORKING SET) : 0.2750 REMARK 3 BIN FREE R VALUE : 0.3020 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.20 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 759 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.011 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6070 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 52 REMARK 3 SOLVENT ATOMS : 766 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 10.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.80 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.85000 REMARK 3 B22 (A**2) : 1.90000 REMARK 3 B33 (A**2) : -4.75000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.21 REMARK 3 ESD FROM SIGMAA (A) : 0.27 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.26 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.30 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 1.200 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 20.20 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.690 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 3.470 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 4.140 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 5.220 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 6.210 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.38 REMARK 3 BSOL : 59.41 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : DGC4_NGA_PAR.TXT REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : DGC4_NGA_TOP.TXT REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2AHG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 01-AUG-05. REMARK 100 THE DEPOSITION ID IS D_1000033899. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-MAY-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL38B1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU JUPITER 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 58182 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 310585. REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.3 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.97 REMARK 200 COMPLETENESS FOR SHELL (%) : 67.7 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.99 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG10000, TRIS, PH 8.6, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 43.92750 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 47.71650 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 47.52050 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 47.71650 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 43.92750 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 47.52050 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 26 -74.10 -121.78 REMARK 500 ASP A 29 71.68 -152.07 REMARK 500 ASP A 38 52.13 -93.03 REMARK 500 ASP A 41 -166.04 -116.38 REMARK 500 SER A 96 -77.34 -114.54 REMARK 500 ILE A 205 -71.10 -122.15 REMARK 500 ASP A 278 84.51 -151.64 REMARK 500 SER A 345 65.92 37.71 REMARK 500 ASP A 347 70.82 -153.46 REMARK 500 HIS B 26 -80.42 -121.10 REMARK 500 ASP B 38 56.92 -96.56 REMARK 500 ASP B 41 -168.10 -117.52 REMARK 500 GLU B 61 -19.07 -48.10 REMARK 500 ASN B 88 24.35 -69.28 REMARK 500 SER B 96 -81.01 -121.08 REMARK 500 PRO B 140 25.23 -72.55 REMARK 500 GLU B 141 -32.04 -172.47 REMARK 500 GLU B 200 -79.92 -67.58 REMARK 500 ILE B 205 -59.60 -120.26 REMARK 500 ASP B 347 66.54 -152.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2AHF RELATED DB: PDB REMARK 900 THE SAME ENZYME (APO FORM) DBREF 2AHG A 1 377 UNP Q9RC92 UGL_BACGL 1 377 DBREF 2AHG B 1 377 UNP Q9RC92 UGL_BACGL 1 377 SEQADV 2AHG ASN A 88 UNP Q9RC92 ASP 88 ENGINEERED MUTATION SEQADV 2AHG ASN B 88 UNP Q9RC92 ASP 88 ENGINEERED MUTATION SEQRES 1 A 377 MET TRP GLN GLN ALA ILE GLY ASP ALA LEU GLY ILE THR SEQRES 2 A 377 ALA ARG ASN LEU LYS LYS PHE GLY ASP ARG PHE PRO HIS SEQRES 3 A 377 VAL SER ASP GLY SER ASN LYS TYR VAL LEU ASN ASP ASN SEQRES 4 A 377 THR ASP TRP THR ASP GLY PHE TRP SER GLY ILE LEU TRP SEQRES 5 A 377 LEU CYS TYR GLU TYR THR GLY ASP GLU GLN TYR ARG GLU SEQRES 6 A 377 GLY ALA VAL ARG THR VAL ALA SER PHE ARG GLU ARG LEU SEQRES 7 A 377 ASP ARG PHE GLU ASN LEU ASP HIS HIS ASN ILE GLY PHE SEQRES 8 A 377 LEU TYR SER LEU SER ALA LYS ALA GLN TRP ILE VAL GLU SEQRES 9 A 377 LYS ASP GLU SER ALA ARG LYS LEU ALA LEU ASP ALA ALA SEQRES 10 A 377 ASP VAL LEU MET ARG ARG TRP ARG ALA ASP ALA GLY ILE SEQRES 11 A 377 ILE GLN ALA TRP GLY PRO LYS GLY ASP PRO GLU ASN GLY SEQRES 12 A 377 GLY ARG ILE ILE ILE ASP CYS LEU LEU ASN LEU PRO LEU SEQRES 13 A 377 LEU LEU TRP ALA GLY GLU GLN THR GLY ASP PRO GLU TYR SEQRES 14 A 377 ARG ARG VAL ALA GLU ALA HIS ALA LEU LYS SER ARG ARG SEQRES 15 A 377 PHE LEU VAL ARG GLY ASP ASP SER SER TYR HIS THR PHE SEQRES 16 A 377 TYR PHE ASP PRO GLU ASN GLY ASN ALA ILE ARG GLY GLY SEQRES 17 A 377 THR HIS GLN GLY ASN THR ASP GLY SER THR TRP THR ARG SEQRES 18 A 377 GLY GLN ALA TRP GLY ILE TYR GLY PHE ALA LEU ASN SER SEQRES 19 A 377 ARG TYR LEU GLY ASN ALA ASP LEU LEU GLU THR ALA LYS SEQRES 20 A 377 ARG MET ALA ARG HIS PHE LEU ALA ARG VAL PRO GLU ASP SEQRES 21 A 377 GLY VAL VAL TYR TRP ASP PHE GLU VAL PRO GLN GLU PRO SEQRES 22 A 377 SER SER TYR ARG ASP SER SER ALA SER ALA ILE THR ALA SEQRES 23 A 377 CYS GLY LEU LEU GLU ILE ALA SER GLN LEU ASP GLU SER SEQRES 24 A 377 ASP PRO GLU ARG GLN ARG PHE ILE ASP ALA ALA LYS THR SEQRES 25 A 377 THR VAL THR ALA LEU ARG ASP GLY TYR ALA GLU ARG ASP SEQRES 26 A 377 ASP GLY GLU ALA GLU GLY PHE ILE ARG ARG GLY SER TYR SEQRES 27 A 377 HIS VAL ARG GLY GLY ILE SER PRO ASP ASP TYR THR ILE SEQRES 28 A 377 TRP GLY ASP TYR TYR TYR LEU GLU ALA LEU LEU ARG LEU SEQRES 29 A 377 GLU ARG GLY VAL THR GLY TYR TRP TYR GLU ARG GLY ARG SEQRES 1 B 377 MET TRP GLN GLN ALA ILE GLY ASP ALA LEU GLY ILE THR SEQRES 2 B 377 ALA ARG ASN LEU LYS LYS PHE GLY ASP ARG PHE PRO HIS SEQRES 3 B 377 VAL SER ASP GLY SER ASN LYS TYR VAL LEU ASN ASP ASN SEQRES 4 B 377 THR ASP TRP THR ASP GLY PHE TRP SER GLY ILE LEU TRP SEQRES 5 B 377 LEU CYS TYR GLU TYR THR GLY ASP GLU GLN TYR ARG GLU SEQRES 6 B 377 GLY ALA VAL ARG THR VAL ALA SER PHE ARG GLU ARG LEU SEQRES 7 B 377 ASP ARG PHE GLU ASN LEU ASP HIS HIS ASN ILE GLY PHE SEQRES 8 B 377 LEU TYR SER LEU SER ALA LYS ALA GLN TRP ILE VAL GLU SEQRES 9 B 377 LYS ASP GLU SER ALA ARG LYS LEU ALA LEU ASP ALA ALA SEQRES 10 B 377 ASP VAL LEU MET ARG ARG TRP ARG ALA ASP ALA GLY ILE SEQRES 11 B 377 ILE GLN ALA TRP GLY PRO LYS GLY ASP PRO GLU ASN GLY SEQRES 12 B 377 GLY ARG ILE ILE ILE ASP CYS LEU LEU ASN LEU PRO LEU SEQRES 13 B 377 LEU LEU TRP ALA GLY GLU GLN THR GLY ASP PRO GLU TYR SEQRES 14 B 377 ARG ARG VAL ALA GLU ALA HIS ALA LEU LYS SER ARG ARG SEQRES 15 B 377 PHE LEU VAL ARG GLY ASP ASP SER SER TYR HIS THR PHE SEQRES 16 B 377 TYR PHE ASP PRO GLU ASN GLY ASN ALA ILE ARG GLY GLY SEQRES 17 B 377 THR HIS GLN GLY ASN THR ASP GLY SER THR TRP THR ARG SEQRES 18 B 377 GLY GLN ALA TRP GLY ILE TYR GLY PHE ALA LEU ASN SER SEQRES 19 B 377 ARG TYR LEU GLY ASN ALA ASP LEU LEU GLU THR ALA LYS SEQRES 20 B 377 ARG MET ALA ARG HIS PHE LEU ALA ARG VAL PRO GLU ASP SEQRES 21 B 377 GLY VAL VAL TYR TRP ASP PHE GLU VAL PRO GLN GLU PRO SEQRES 22 B 377 SER SER TYR ARG ASP SER SER ALA SER ALA ILE THR ALA SEQRES 23 B 377 CYS GLY LEU LEU GLU ILE ALA SER GLN LEU ASP GLU SER SEQRES 24 B 377 ASP PRO GLU ARG GLN ARG PHE ILE ASP ALA ALA LYS THR SEQRES 25 B 377 THR VAL THR ALA LEU ARG ASP GLY TYR ALA GLU ARG ASP SEQRES 26 B 377 ASP GLY GLU ALA GLU GLY PHE ILE ARG ARG GLY SER TYR SEQRES 27 B 377 HIS VAL ARG GLY GLY ILE SER PRO ASP ASP TYR THR ILE SEQRES 28 B 377 TRP GLY ASP TYR TYR TYR LEU GLU ALA LEU LEU ARG LEU SEQRES 29 B 377 GLU ARG GLY VAL THR GLY TYR TRP TYR GLU ARG GLY ARG HET NGA C 1 15 HET GCD C 2 11 HET NGA D 1 15 HET GCD D 2 11 HETNAM NGA 2-ACETAMIDO-2-DEOXY-BETA-D-GALACTOPYRANOSE HETNAM GCD 4-DEOXY-ALPHA-L-THREO-HEX-4-ENOPYRANURONIC ACID HETSYN NGA N-ACETYL-BETA-D-GALACTOSAMINE; 2-ACETAMIDO-2-DEOXY- HETSYN 2 NGA BETA-D-GALACTOSE; 2-ACETAMIDO-2-DEOXY-D-GALACTOSE; 2- HETSYN 3 NGA ACETAMIDO-2-DEOXY-GALACTOSE; N-ACETYL-D-GALACTOSAMINE HETSYN GCD 4,5-DEHYDRO-D-GLUCURONIC ACID; 4-DEOXY-ALPHA-L-THREO- HETSYN 2 GCD HEX-4-ENURONIC ACID; 4-DEOXY-L-THREO-HEX-4-ENURONIC HETSYN 3 GCD ACID; 4-DEOXY-THREO-HEX-4-ENURONIC ACID FORMUL 3 NGA 2(C8 H15 N O6) FORMUL 3 GCD 2(C6 H8 O6) FORMUL 5 HOH *766(H2 O) HELIX 1 1 TRP A 2 GLY A 21 1 20 HELIX 2 2 THR A 43 GLY A 59 1 17 HELIX 3 3 ASP A 60 ASP A 79 1 20 HELIX 4 4 ASN A 88 LEU A 95 1 8 HELIX 5 5 SER A 96 LYS A 105 1 10 HELIX 6 6 ASP A 106 ARG A 122 1 17 HELIX 7 7 ASP A 149 LEU A 152 5 4 HELIX 8 8 ASN A 153 GLY A 165 1 13 HELIX 9 9 PRO A 167 LEU A 184 1 18 HELIX 10 10 TRP A 219 GLY A 238 1 20 HELIX 11 11 ASN A 239 ALA A 255 1 17 HELIX 12 12 ASP A 278 LEU A 296 1 19 HELIX 13 13 ASP A 300 TYR A 321 1 22 HELIX 14 14 THR A 350 GLY A 367 1 18 HELIX 15 15 TRP B 2 GLY B 21 1 20 HELIX 16 16 THR B 43 GLY B 59 1 17 HELIX 17 17 ASP B 60 ARG B 80 1 21 HELIX 18 18 ASN B 88 LEU B 95 1 8 HELIX 19 19 SER B 96 LYS B 105 1 10 HELIX 20 20 ASP B 106 MET B 121 1 16 HELIX 21 21 ASP B 149 LEU B 152 5 4 HELIX 22 22 ASN B 153 GLY B 165 1 13 HELIX 23 23 PRO B 167 LEU B 184 1 18 HELIX 24 24 TRP B 219 GLY B 238 1 20 HELIX 25 25 ASN B 239 ALA B 255 1 17 HELIX 26 26 ASP B 278 GLN B 295 1 18 HELIX 27 27 ASP B 300 ALA B 322 1 23 HELIX 28 28 THR B 350 GLY B 367 1 18 SHEET 1 A 2 PHE A 24 SER A 28 0 SHEET 2 A 2 TYR A 34 ASN A 37 -1 O ASN A 37 N PHE A 24 SHEET 1 B 2 TRP A 124 ARG A 125 0 SHEET 2 B 2 ILE A 130 ILE A 131 -1 O ILE A 130 N ARG A 125 SHEET 1 C 3 ARG A 145 ILE A 147 0 SHEET 2 C 3 THR A 194 PHE A 197 -1 O PHE A 195 N ILE A 146 SHEET 3 C 3 ALA A 204 GLY A 208 -1 O GLY A 208 N THR A 194 SHEET 1 D 2 PHE B 24 SER B 28 0 SHEET 2 D 2 TYR B 34 ASN B 37 -1 O ASN B 37 N PHE B 24 SHEET 1 E 2 TRP B 124 ARG B 125 0 SHEET 2 E 2 ILE B 130 ILE B 131 -1 O ILE B 130 N ARG B 125 SHEET 1 F 3 ARG B 145 ILE B 147 0 SHEET 2 F 3 THR B 194 PHE B 197 -1 O PHE B 195 N ILE B 146 SHEET 3 F 3 ALA B 204 GLY B 208 -1 O GLY B 208 N THR B 194 LINK O3 NGA C 1 C1 GCD C 2 1555 1555 1.44 LINK O3 NGA D 1 C1 GCD D 2 1555 1555 1.44 CRYST1 87.855 95.041 95.433 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011382 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010522 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010479 0.00000